
Patients suffering from persistent COVID‐19 olfactory dysfunction (OD) commonly report parosmia. Understanding the impact of COVID‐19 OD and parosmia is critical to prioritizing research and interventions. This study investigates the impact of parosmia and other clinical and disease characteristics on health state utility values (HUVs) for those with persistent COVID‐19 OD. Patients with a history of COVID‐19 diagnosis and persistent OD were recruited from a tertiary medical center and a social media support forum for chemosensory dysfunction. Clinical characteristics and disease specific symptoms were obtained along with self‐reported history of smell function and presence of parosmia. HUVs were calculated using indirect (EuroQol‐5Dimension, [EQ‐5D]) and direct measures (VAS)...
Like
Save
Share